Browsing: KMT2Ar
FollowPlay Earnings CallPlay Earnings Call Kura Oncology, Inc. (KURA) Discusses Ziftomenib Combination Data in Newly Diagnosed and Relapsed/Refractory NPM1-m and…
FollowPlay Earnings CallPlay Earnings Call Kura Oncology, Inc. (KURA) Discusses Ziftomenib Combination Data in Newly Diagnosed and Relapsed/Refractory NPM1-m and…